Christopher MacLeod

Executive

Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.)

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 1 buy · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€5,395

▼ Sales (0 ops.)

—

Latest filing published 18 Mar 2025 for Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.), €5,395.

Filing timeline

BuySale

Christopher MacLeod

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Christopher MacLeod: trading record in brief

Only one filing by Christopher MacLeod is known so far (18 March 2025): an open-market purchase, €5,395, in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). That is too little to draw conclusions. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.